Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATHERINE C NICKELS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Epilepsy

NPI
1679545354
CMS profile
1094258
Location
ROCHESTER, MN

General Payments · PY2022–2024

$22,816.71

  • Reported across 30 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$9,361.85

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $8,046.00 1
Travel and Lodging $742.41 5
Food and Beverage $573.44 10

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $9,162.18 15
UCB, Inc. $199.67 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $9,429.69 9
PY2023 $4,025.17 5
PY2024 $9,361.85 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $385.96 04/29/2024 Travel and Lodging Undisputed 01/23/2026 1137643872 CMS
Takeda Pharmaceuticals U.S.A., Inc. $54.95 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1137643874 CMS
Takeda Pharmaceuticals U.S.A., Inc. $124.99 05/17/2024 Food and Beverage Undisputed 01/23/2026 1137643876 CMS
Takeda Pharmaceuticals U.S.A., Inc. $49.99 05/17/2024 Food and Beverage Undisputed 01/23/2026 1137643878 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3.36 05/17/2024 Food and Beverage Undisputed 01/23/2026 1137643880 CMS
Takeda Pharmaceuticals U.S.A., Inc. $49.99 05/17/2024 Food and Beverage Undisputed 01/23/2026 1137643882 CMS
Takeda Pharmaceuticals U.S.A., Inc. $57.00 05/18/2024 Travel and Lodging Undisputed 01/23/2026 1137643884 CMS
Takeda Pharmaceuticals U.S.A., Inc. $54.95 05/18/2024 Travel and Lodging Undisputed 01/23/2026 1137643886 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.36 05/18/2024 Food and Beverage Undisputed 01/23/2026 1137643888 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.84 05/18/2024 Food and Beverage Undisputed 01/23/2026 1137643890 CMS
Takeda Pharmaceuticals U.S.A., Inc. $74.99 05/18/2024 Food and Beverage Undisputed 01/23/2026 1137643892 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.89 05/18/2024 Food and Beverage Undisputed 01/23/2026 1137643894 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3.36 05/18/2024 Food and Beverage Undisputed 01/23/2026 1137643896 CMS
Takeda Pharmaceuticals U.S.A., Inc. $189.55 05/18/2024 Travel and Lodging Undisputed 01/23/2026 1137643898 CMS
Takeda Pharmaceuticals U.S.A., Inc. $8,046.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 1137643900 CMS
UCB, Inc. $199.67 12/08/2024 Food and Beverage Undisputed 01/23/2026 1143093579 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.